BIOPREMIER CLINICAL develops new tests for the detection of pathogenic microorganisms and infectious diseases. Biopremier was granted with several R&D projects, whether individually or in collaboration with other companies and hospitals, which allow the company to proceed to a faster development of the new tests.
Presently, the company is developing two new diagnostic kits for the clinical sector, applied to respiratory and gastrointestinal infectious diseases.
Additionally, the company is continously developing and validating new Accredited DNA tests for the Veterinary and Clinical sectors, namely for Detection and Identification of pathogenic microorganisms.
BIOPREMIER facilities are composed by brand new laboratories that were built to ensure high levels of quality and safety. Depending on the methodologies and biological material, the laboratory activities are performed in separated rooms that enable a unidirectional step-forward route of the biological samples.